Malignant Hypertension in a Patient with Primary Aldosteronism with Elevated Active Renin Concentration

Internal Medicine

Volumn 36, Issue 10, 1997, Pages 700-704

  Oka, Kiyoshi ^a   Hayashi, Koichi ^a   Nakazato, Tomonori ^a   Suzawa, Taichi ^a   Fujiwara, Keiji ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Adrenal adenoma; Aldosterone; Hemolytic anemia; Hypertension; Renal injury; Renin

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; CREATININE; RENIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADRENALECTOMY; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CASE REPORT; HUMAN; HYPERALDOSTERONISM; MALE; MALIGNANT HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CREATININE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION, MALIGNANT; MAGNETIC RESONANCE IMAGING; MALE; RENIN;

EID: 0031243743     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.700     Document Type: Article

References (19)

1. Conn JW. Part I, Painting background. Pan II. Primary aldosteronism. a new clinical syndrome. J Lab Clin Med 43: 3, 1955.
2. Conn JW. Aldosteronism in man; Some clinical and climatological aspects. Part II. JAMA 183: 871, 1963.
3. Conn JW, Knopf RF, Nesbit RM. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107: 159, 1964.
4. Conn JW, Cohen ED, Rovner DR. Suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. JAMA 190: 213, 1964.
5. Conn JW, Cohen ED, Rovner DR, Nesbit RM. Normokalemic primary aldosteronism. A detectable cause of curable "essential" hypertension. JAMA 193: 200, 1965.
6. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 55: 261, 1973.
7. Kaplan NM. Primary aldosteronism with malignant hypertension. N Engl J Med 269: 1282, 1963.
8. Del Greco F, Dolkart R, Skom J, Method H. Association of accelerated (malignant) hypertension in a patient with primary aldosteronism. J Clin Endocrinol Metab 26: 808, 1966.
9. McAllister RG Jr, Van Way CW, Dayani K, et al. Malignant hypertension: Effect of therapy on renin and aldosterone. Circ Res 28: Suppl 2: 160, 1971.
10. Baglin A, Weiss Y, Safar M, Milliez P. Hyperaldosteronisme primaire avec hypertension maligne. La Nouvelle Presse medicale 2: 295, 1973 (in French).
11. Aloia JF, Beutow G. Malignant hypertension with aldosteronoma producing adenoma. Am J Med Sci 268: 241, 1974.
12. Baxter RH, Wang I. Malignant hypertension in a patient with Conn's syndrome. Scott Med J 19: 161, 1974.
13. Iyori S, Saruta T, Kondo K, Ozawa Y, Hata J, Shimizu K. Renin and juxtaglomerular apparatus in a patient with primary aldosteronism complicated by chronic renal failure. South Med J 69: 951, 1976.
14. Murphy BF, Whitworth JA. Kincaid-Smith P. Malignant hypertension due to an aldosterone producing adrenal adenoma. Clin Exp Hypertens [A] 7: 939, 1985.
15. IwaokaT, Umeda T, Sato T, Katsuragi S, Takeuchi T. High plasma renin activities in primary aldosteronism with malignant hypertension. A case report. Jpn Heart J 21: 423, 1980.
16. Bravo EL, Fouad-Tarazi FM, Tarazi RC, Pohl M, Gifford RW, Vidt DG. Clinical implications of primary aldosteronism with resistant hypertension. Hypertension 11: 1207, 1988.
17. Sunman W, Rothwell M, Sever PS. Conn's syndrome can cause malignant hypertension. J Hum Hypertens 6: 75, 1992.
18. Obana M, Hayakawa Y, Higashi F, et al. A case of primary aldosteronism with chronic renal failure (author's transl). Nippon Jinzo Gakkai Shi 22: 51, 1980 (in Japanese).
19. Inaba M, Nakamura K, Isogai S, et al. A case report of primary aldosteronism with bilateral multiple adrenal adenoma. Nippon Naika Gakkaishi 66: 128, 1977 (Abstract in Japanese).